Chronic tamoxifen use is associated with a decreased risk of intestinal metaplasia in human gastric epithelium

Chang Mo Moon, Seok Hyung Kim, Sang Kil Lee, Jiyeon Hyeon, Ja Seung Koo, Sangheun Lee, Jean S. Wang, Won Jae Huh, Shradha S. Khurana, Jason C. Mills

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Background: Intestinal metaplasia (IM), a premalignant lesion, is associated with an increased risk of gastric cancer. Although estrogen exposure, including tamoxifen, has been studied in correlation with gastric cancer, little has been investigated about its effects on IM. Aims: Therefore, we investigated whether chronic tamoxifen use was associated with the risk of IM in human stomach. Methods: We evaluated 512 gastric biopsies from 433 female breast cancer patients that underwent endoscopic gastroduodenoscopy (EGD) ≥6 months after breast surgery. Histopathological findings were scored according to the updated Sydney classification. Demographic and clinical characteristics were also included to identify predictive factors for IM. Results: In a multivariate logistic regression analysis, age at EGD (odds ratio [OR], 1.04; P = 0.002), biopsies from antrum (OR 2.08; P < 0.001), and Helicobacter pylori positivity (OR 1.68; P = 0.016) were significantly associated with an increased risk of IM, whereas chronic tamoxifen use (≥3 months) was associated with a decreased risk of IM (OR 0.59; P = 0.025). After stratifying by biopsy site, association between tamoxifen use and IM persisted for corpus (OR 0.42; P = 0.026) but not for antrum (OR 0.74; P = 0.327). In analysis limited to patients with follow-up EGD, chronic tamoxifen use also correlated with improved IM score compared to no tamoxifen use (improved, 77.8 vs. 22.2 %; no change, 65.4 vs. 34.6 %; worsened, 30.0 vs. 70.0 %; P = 0.019). Conclusions: This study suggests that chronic tamoxifen use can decrease the risk of IM in human stomach. The effect of tamoxifen is predominantly observed in the corpus.

Original languageEnglish
Pages (from-to)1244-1254
Number of pages11
JournalDigestive Diseases and Sciences
Issue number6
StatePublished - Jun 2014

Bibliographical note

Funding Information:
Acknowledgments This study was supported by grants to Jason C. Mills from the Washington University Institute of Clinical and Translational Sciences grant #UL1 TR000448 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH), the American Cancer Society (DDC-115769), NIH NIDDK (DK 094989), and Washington University Digestive Disease Research Core Center (Grant #5P30-DK052574).


  • Corpus
  • Gastric epithelium
  • Intestinal metaplasia
  • Tamoxifen


Dive into the research topics of 'Chronic tamoxifen use is associated with a decreased risk of intestinal metaplasia in human gastric epithelium'. Together they form a unique fingerprint.

Cite this